ECO Animal Health achieves A-rating for its ESG activities from Integrum ESG

ECO Animal Health Group plc (LON:EAH), a leader in the development, registration and marketing of pharmaceutical products for global animal health markets, has announced that it has achieved an A-rating for its ESG activities from Integrum ESG, who provide independent ESG ratings to a large number of companies.

An ‘A’ rating is the highest score possible and higher than approximately 300 other companies ranked in the same sub-sector. The rating reflects the ECO ESG strategy and activities and metrics, which are focused especially on environmental and social, particularly ethnic and gender diversity, aspects.

David Hallas, ECO Animal Health CEO commented: “ECO is committed to embedding sustainability into the high standards set for its business dealings. We recognise the value of incorporating the principles of Environment, Social and Governance (ESG) into everything we do and aspire to contribute to six of the UN SDGs which are aligned with our current and future business and intentions.”

Click to view all articles for the EPIC:
Or click to view the full company profile:
Facebook
X
LinkedIn
ECO Animal Health Group plc

More articles like this

ECO Animal Health Group plc

ECO Animal Health disposes of ECOmectin® to ACME for €1.3m

ECO Animal Health Group plc (LON:EAH), a rapidly growing global animal health company with a portfolio of marketed veterinary products and a maturing proprietary R&D pipeline, has announced the disposal of ECOmectin® Horsepaste to ACME Drugs S.r.l in Italy,

ECO Animal Health Group plc

ECO Animal Health ECOVAXXIN® trademark approved by the EU

ECO Animal Health Group plc (LON:EAH), a rapidly growing global animal health company with a portfolio of marketed veterinary products and a maturing proprietary R&D pipeline, has announced that the ECOVAXXIN® trademark has been approved by the European

ECO Animal Health Group plc

ECO Animal Health completes sale of freehold properties

ECO Animal Health Group plc (LON:EAH) has announced that on 5 January 2024 the Company completed the sale of its freehold property in New Malden, Surrey.  This was the former registered office of the Company and following

ECO Animal Health Group plc

ECO Animal Health to host two Capital Markets events

ECO Animal Health Group plc (LON:EAH), a leader in the development, registration and marketing of pharmaceutical products for global animal health markets, has announced that it will be hosting two Capital Markets events focused on progress and

ECO Animal Health Group plc

ECO Animal Health Group Retail Investor Presentation

ECO Animal Health Group plc (LON:EAH), a leader in the development, registration and marketing of pharmaceutical products for global animal health markets, will be hosting a Capital Markets Day presentation for retail investors focusing on progress

ECO Animal Health Group plc

ECO Animal Health AGM to be held on Thursday 7 September 2023

ECO Animal Health Group plc (LON:EAH), a leader in the development, registration and marketing of pharmaceutical products for global animal health markets, has announced that the Company is today posting to shareholders notice of the Company’s Annual

ECO Animal Health Group plc

ECO Animal Health Group revenue ahead of market expectations

ECO Animal Health Group plc (LON:EAH) have today provided final results for the year ended 31 March 2023. HIGHLIGHTS Financial ·      Revenue and adjusted EBITDA ahead of market expectations ·      Group sales increased by 4% to £85.3m, driven primarily